{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T04:13:31Z","timestamp":1747455211824},"reference-count":13,"publisher":"Japanese Society of Internal Medicine","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2020,6,1]]},"DOI":"10.2169\/internalmedicine.4085-19","type":"journal-article","created":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T22:09:34Z","timestamp":1583359774000},"page":"1437-1443","source":"Crossref","is-referenced-by-count":2,"title":["Magnetic Resonance Imaging-negative, Rituximab-resistant Neurolymphomatosis as a Paradoxical Presentation of Relapsed Primary Adrenal Lymphoma"],"prefix":"10.2169","volume":"59","author":[{"given":"Mayuka","family":"Nishikawara","sequence":"first","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Shinshu University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Kawakami","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Shinshu University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Sakai","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Shinshu University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumihiro","family":"Kawakami","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Shinshu University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayaka","family":"Nishina","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Shinshu University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Uehara","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Shinshu University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumihiro","family":"Ishida","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Shinshu University School of Medicine, Japan"},{"name":"Department of Biomedical Laboratory Medicine, Shinshu University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideyuki","family":"Nakazawa","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Shinshu University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Ollila TA, Olszewski AJ. Extranodal diffuse large B cell lymphoma: molecular features, prognosis, and risk of central nervous system recurrence. Curr Treat Options Oncol 19: 38, 2018."},{"key":"2","unstructured":"2. Castillo JJ, Winer ES, Olszewski AJ. Sites of extranodal involvement are prognostic in patients with diffuse large B-cell lymphoma in the rituximab era: an analysis of the Surveillance, Epidemiology and End Results database. Am J Hematol 89: 310-314, 2014."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. International Non-Hodgkin's Lymphoma Prognostic Factors P. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 329: 987-994, 1993.","DOI":"10.1056\/NEJM199309303291402"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Zhou Z, Sehn LH, Rademaker AW, et al. An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. Blood 123: 837-842, 2014.","DOI":"10.1182\/blood-2013-09-524108"},{"key":"5","unstructured":"5. Rashidi A, Fisher SI. Primary adrenal lymphoma: a systematic review. Ann Hematol 92: 1583-1593, 2013."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Ferreri AJ. Risk of CNS dissemination in extranodal lymphomas. Lancet Oncol 15: e159-e169, 2014.","DOI":"10.1016\/S1470-2045(13)70568-0"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Grisariu S, Avni B, Batchelor TT, et al. Neurolymphomatosis: an International Primary CNS Lymphoma Collaborative Group report. Blood 115: 5005-5011, 2010.","DOI":"10.1182\/blood-2009-12-258210"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Baehring JM, Damek D, Martin EC, Betensky RA, Hochberg FH. Neurolymphomatosis. Neuro Oncol 5: 104-115, 2003.","DOI":"10.1215\/15228517-5-2-104"},{"key":"9","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/neuonc\/nop021","volume":"12","author":"HK Gan","year":"2009","unstructured":"9. Gan HK, Azad A, Cher L, Mitchell PLR. Neurolymphomatosis: diagnosis, management, and outcomes in patients treated with rituximab. Neuro-Oncology 12: 212-215, 2009.","journal-title":"Neuro-Oncology","ISSN":"http:\/\/id.crossref.org\/issn\/1522-8517","issn-type":"print"},{"key":"10","unstructured":"10. Bourque PR, Warman Chardon J, Bryanton M, Toupin M, Burns BF, Torres C. Neurolymphomatosis of the brachial plexus and its branches: case series and literature review. Can J Neurol Sci 45: 137-143, 2018."},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Matsue K, Hayama BY, Iwama K, et al. High frequency of neurolymphomatosis as a relapse disease of intravascular large B-cell lymphoma. Cancer 117: 4512-4521, 2011.","DOI":"10.1002\/cncr.26090"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Mozos A, Ye H, Chuang WY, et al. Most primary adrenal lymphomas are diffuse large B-cell lymphomas with non-germinal center B-cell phenotype, BCL6 gene rearrangement and poor prognosis. Mod Pathol 22: 1210-1217, 2009.","DOI":"10.1038\/modpathol.2009.87"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Abe Y, Narita K, Kobayashi H, et al. Clinical value of abnormal findings on brain magnetic resonance imaging in patients with intravascular large B-cell lymphoma. Ann Hematol 97: 2345-2352, 2018.","DOI":"10.1007\/s00277-018-3481-8"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/11\/59_4085-19\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,6]],"date-time":"2020-06-06T03:41:41Z","timestamp":1591414901000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/11\/59_4085-19\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,1]]},"references-count":13,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.4085-19","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,1]]}}}